ArticlePloS one2025

Exploring common genomic biomarkers to disclose common drugs for the treatment of colorectal cancer and hepatocellular carcinoma with type-2 diabetes through transcriptomics analysis.

Sabkat Mahmud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.